4978 — ReproCell Balance Sheet
0.000.00%
- ¥17bn
- ¥12bn
- ¥3bn
- 31
- 16
- 75
- 33
Annual balance sheet for ReproCell, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,601 | 4,642 | 6,379 | 6,567 | 3,942 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 180 | 348 | 446 | 421 | 464 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,245 | 5,379 | 7,182 | 7,399 | 4,896 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 174 | 97.8 | 101 | 200 | 242 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,047 | 8,095 | 8,356 | 9,053 | 9,671 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 553 | 827 | 750 | 678 | 641 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 663 | 845 | 781 | 741 | 686 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,384 | 7,251 | 7,575 | 8,312 | 8,985 |
| Total Liabilities & Shareholders' Equity | 6,047 | 8,095 | 8,356 | 9,053 | 9,671 |
| Total Common Shares Outstanding |